List of Contents

Biobanking Market Size, Share, and Trends 2024 to 2034

The global biobanking market size is estimated at USD 89.69 billion in 2025 and is forecasted to reach around USD 182.00 billion by 2034, accelerating at a CAGR of 8.16% from 2025 to 2034. The Europe biobanking market size surpassed USD 32.29 billion in 2025 and is expanding at a CAGR of 8.31% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1641
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Biobanking Market, By Service

7.1. Biobanking Market, by Service

7.1.1. Biobanking and Repository

7.1.1.1. Market Revenue and Forecast

7.1.2. Validation/Qualification

7.1.2.1. Market Revenue and Forecast

7.1.3. Lab Processing

7.1.3.1. Market Revenue and Forecast

7.1.4. Cold Chain Logistic

7.1.4.1. Market Revenue and Forecast

7.1.5. Other

7.1.5.1. Market Revenue and Forecast

Chapter 8. Global Biobanking Market, By Product

8.1. Biobanking Market, by Product

8.1.1. Equipment

8.1.1.1. Market Revenue and Forecast

8.1.2. Consumables

8.1.2.1. Market Revenue and Forecast

8.1.3. Laboratory Information Systems

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Biobanking Market, By Biospecimen

9.1. Biobanking Market, by Biospecimen

9.1.1. Human Tissues

9.1.1.1. Market Revenue and Forecast

9.1.2. Stem Cells

9.1.2.1. Market Revenue and Forecast

9.1.3. Organs

9.1.3.1. Market Revenue and Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Forecast

Chapter 10. Global Biobanking Market, By Biobank

10.1. Biobanking Market, by Biobank

10.1.1. Physical Biobanks

10.1.1.1. Market Revenue and Forecast

10.1.2. Virtual Biobanks

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Biobanking Market, By End-use

11.1. Biobanking Market, by End-use

11.1.1. Drug Discovery and Clinical Research

11.1.1.1. Market Revenue and Forecast

11.1.2. Therapeutics

11.1.2.1. Market Revenue and Forecast

11.1.3. Clinical Diagnostics

11.1.3.1. Market Revenue and Forecast

11.1.4. Others

11.1.4.1. Market Revenue and Forecast

Chapter 12. Global Biobanking Market, By Type of Biobank

12.1. Biobanking Market, by Type of Biobank

12.1.1. Population-based Biobanks

12.1.1.1. Market Revenue and Forecast

12.1.2. Disease-oriented Biobanks

12.1.2.1. Market Revenue and Forecast

Chapter 13. Global Biobanking Market, By Ownership

13.1. Biobanking Market, by Ownership

13.1.1. National/regional agency

13.1.1.1. Market Revenue and Forecast

13.1.2. Non-Profit Organization

13.1.2.1. Market Revenue and Forecast

13.1.3. Universities

13.1.3.1. Market Revenue and Forecast

13.1.4. Private Organization

13.1.4.1. Market Revenue and Forecast

Chapter 14. Global Biobanking Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Service

14.1.2. Market Revenue and Forecast, by Product

14.1.3. Market Revenue and Forecast, by Biospecimen

14.1.4. Market Revenue and Forecast, by Biobank

14.1.5. Market Revenue and Forecast, by End-use

14.1.6. Market Revenue and Forecast, by Ownership

14.1.7. Market Revenue and Forecast, by Type of Biobank

14.1.8. U.S.

14.1.8.1. Market Revenue and Forecast, by Service

14.1.8.2. Market Revenue and Forecast, by Product

14.1.8.3. Market Revenue and Forecast, by Biospecimen

14.1.8.4. Market Revenue and Forecast, by Biobank

14.1.8.5. Market Revenue and Forecast, by End-use

14.1.8.6. Market Revenue and Forecast, by Ownership

14.1.8.7. Market Revenue and Forecast, by Type of Biobank

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Service

14.1.9.2. Market Revenue and Forecast, by Product

14.1.9.3. Market Revenue and Forecast, by Biospecimen

14.1.9.4. Market Revenue and Forecast, by Biobank

14.1.9.5. Market Revenue and Forecast, by End-use

14.1.9.6. Market Revenue and Forecast, by Ownership

14.1.9.7. Market Revenue and Forecast, by Type of Biobank

14.2. Europe

14.2.1. Market Revenue and Forecast, by Service

14.2.2. Market Revenue and Forecast, by Product

14.2.3. Market Revenue and Forecast, by Biospecimen

14.2.4. Market Revenue and Forecast, by Biobank

14.2.5. Market Revenue and Forecast, by End-use

14.2.6. Market Revenue and Forecast, by Ownership

14.2.7. Market Revenue and Forecast, by Type of Biobank

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Service

14.2.8.2. Market Revenue and Forecast, by Product

14.2.8.3. Market Revenue and Forecast, by Biospecimen

14.2.8.4. Market Revenue and Forecast, by Biobank

14.2.8.5. Market Revenue and Forecast, by End-use

14.2.8.6. Market Revenue and Forecast, by Ownership

14.2.8.7. Market Revenue and Forecast, by Type of Biobank

14.2.9. Germany

14.2.9.1. Market Revenue and Forecast, by Service

14.2.9.2. Market Revenue and Forecast, by Product

14.2.9.3. Market Revenue and Forecast, by Biospecimen

14.2.9.4. Market Revenue and Forecast, by Biobank

14.2.9.5. Market Revenue and Forecast, by End-use

14.2.9.6. Market Revenue and Forecast, by Ownership

14.2.9.7. Market Revenue and Forecast, by Type of Biobank

14.2.10. France

14.2.10.1. Market Revenue and Forecast, by Service

14.2.10.2. Market Revenue and Forecast, by Product

14.2.10.3. Market Revenue and Forecast, by Biospecimen

14.2.10.4. Market Revenue and Forecast, by Biobank

14.2.10.5. Market Revenue and Forecast, by End-use

14.2.10.6. Market Revenue and Forecast, by Ownership

14.2.10.7. Market Revenue and Forecast, by Type of Biobank

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Forecast, by Service

14.2.11.2. Market Revenue and Forecast, by Product

14.2.11.3. Market Revenue and Forecast, by Biospecimen

14.2.11.4. Market Revenue and Forecast, by Biobank

14.2.11.5. Market Revenue and Forecast, by End-use

14.2.11.6. Market Revenue and Forecast, by Ownership

14.2.11.7. Market Revenue and Forecast, by Type of Biobank

14.3. APAC

14.3.1. Market Revenue and Forecast, by Service

14.3.2. Market Revenue and Forecast, by Product

14.3.3. Market Revenue and Forecast, by Biospecimen

14.3.4. Market Revenue and Forecast, by Biobank

14.3.5. Market Revenue and Forecast, by End-use

14.3.6. Market Revenue and Forecast, by Ownership

14.3.7. Market Revenue and Forecast, by Type of Biobank

14.3.8. India

14.3.8.1. Market Revenue and Forecast, by Service

14.3.8.2. Market Revenue and Forecast, by Product

14.3.8.3. Market Revenue and Forecast, by Biospecimen

14.3.8.4. Market Revenue and Forecast, by Biobank

14.3.8.5. Market Revenue and Forecast, by End-use

14.3.8.6. Market Revenue and Forecast, by Ownership

14.3.8.7. Market Revenue and Forecast, by Type of Biobank

14.3.9. China

14.3.9.1. Market Revenue and Forecast, by Service

14.3.9.2. Market Revenue and Forecast, by Product

14.3.9.3. Market Revenue and Forecast, by Biospecimen

14.3.9.4. Market Revenue and Forecast, by Biobank

14.3.9.5. Market Revenue and Forecast, by End-use

14.3.9.6. Market Revenue and Forecast, by Ownership

14.3.9.7. Market Revenue and Forecast, by Type of Biobank

14.3.10. Japan

14.3.10.1. Market Revenue and Forecast, by Service

14.3.10.2. Market Revenue and Forecast, by Product

14.3.10.3. Market Revenue and Forecast, by Biospecimen

14.3.10.4. Market Revenue and Forecast, by Biobank

14.3.10.5. Market Revenue and Forecast, by End-use

14.3.10.6. Market Revenue and Forecast, by Ownership

14.3.10.7. Market Revenue and Forecast, by Type of Biobank

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Forecast, by Service

14.3.11.2. Market Revenue and Forecast, by Product

14.3.11.3. Market Revenue and Forecast, by Biospecimen

14.3.11.4. Market Revenue and Forecast, by Biobank

14.3.11.5. Market Revenue and Forecast, by End-use

14.3.11.6. Market Revenue and Forecast, by Ownership

14.3.11.7. Market Revenue and Forecast, by Type of Biobank

14.4. MEA

14.4.1. Market Revenue and Forecast, by Service

14.4.2. Market Revenue and Forecast, by Product

14.4.3. Market Revenue and Forecast, by Biospecimen

14.4.4. Market Revenue and Forecast, by Biobank

14.4.5. Market Revenue and Forecast, by End-use

14.4.6. Market Revenue and Forecast, by Ownership

14.4.7. Market Revenue and Forecast, by Type of Biobank

14.4.8. GCC

14.4.8.1. Market Revenue and Forecast, by Service

14.4.8.2. Market Revenue and Forecast, by Product

14.4.8.3. Market Revenue and Forecast, by Biospecimen

14.4.8.4. Market Revenue and Forecast, by Biobank

14.4.8.5. Market Revenue and Forecast, by End-use

14.4.8.6. Market Revenue and Forecast, by Ownership

14.4.8.7. Market Revenue and Forecast, by Type of Biobank

14.4.9. North Africa

14.4.9.1. Market Revenue and Forecast, by Service

14.4.9.2. Market Revenue and Forecast, by Product

14.4.9.3. Market Revenue and Forecast, by Biospecimen

14.4.9.4. Market Revenue and Forecast, by Biobank

14.4.9.5. Market Revenue and Forecast, by End-use

14.4.9.6. Market Revenue and Forecast, by Ownership

14.4.9.7. Market Revenue and Forecast, by Type of Biobank

14.4.10. South Africa

14.4.10.1. Market Revenue and Forecast, by Service

14.4.10.2. Market Revenue and Forecast, by Product

14.4.10.3. Market Revenue and Forecast, by Biospecimen

14.4.10.4. Market Revenue and Forecast, by Biobank

14.4.10.5. Market Revenue and Forecast, by End-use

14.4.10.6. Market Revenue and Forecast, by Ownership

14.4.10.7. Market Revenue and Forecast, by Type of Biobank

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Forecast, by Service

14.4.11.2. Market Revenue and Forecast, by Product

14.4.11.3. Market Revenue and Forecast, by Biospecimen

14.4.11.4. Market Revenue and Forecast, by Biobank

14.4.11.5. Market Revenue and Forecast, by End-use

14.4.11.6. Market Revenue and Forecast, by Ownership

14.4.11.7. Market Revenue and Forecast, by Type of Biobank

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Service

14.5.2. Market Revenue and Forecast, by Product

14.5.3. Market Revenue and Forecast, by Biospecimen

14.5.4. Market Revenue and Forecast, by Biobank

14.5.5. Market Revenue and Forecast, by End-use

14.5.6. Market Revenue and Forecast, by Ownership

14.5.7. Market Revenue and Forecast, by Type of Biobank

14.5.8. Brazil

14.5.8.1. Market Revenue and Forecast, by Service

14.5.8.2. Market Revenue and Forecast, by Product

14.5.8.3. Market Revenue and Forecast, by Biospecimen

14.5.8.4. Market Revenue and Forecast, by Biobank

14.5.8.5. Market Revenue and Forecast, by End-use

14.5.8.6. Market Revenue and Forecast, by Ownership

14.5.8.7. Market Revenue and Forecast, by Type of Biobank

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Service

14.5.9.2. Market Revenue and Forecast, by Product

14.5.9.3. Market Revenue and Forecast, by Biospecimen

14.5.9.4. Market Revenue and Forecast, by Biobank

14.5.9.5. Market Revenue and Forecast, by End-use

14.5.9.6. Market Revenue and Forecast, by Ownership

14.5.9.7. Market Revenue and Forecast, by Type of Biobank

Chapter 15. Company Profiles

15.1. Thermo Fisher Scientific Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Tecan Trading AG

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. QIAGEN

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Hamilton Company

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Brooks Life Sciences

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. TTP Labtech

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. VWR International, LLC.

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Promega Corporation

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Worthington Industries

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. BD

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

15.11. Merck KGaA

15.11.1. Company Overview

15.11.2. Product Offerings

15.11.3. Financial Performance

15.11.4. Recent Initiatives

15.12. Biokryo GmbH

15.12.1. Company Overview

15.12.2. Product Offerings

15.12.3. Financial Performance

15.12.4. Recent Initiatives

15.13. Cell&Co BioServices

15.13.1. Company Overview

15.13.2. Product Offerings

15.13.3. Financial Performance

15.13.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global biobanking market size was reached at USD 83.05 billion in 2024 and is anticipated to rake USD 182 billion by 2034.

The global biobanking market is growing at a CAGR of 8.16% from 2025 to 2034.

The major players in biobanking market are Thermo Fisher Scientific Inc., Tecan Trading AG, QIAGEN, Hamilton Company, Brooks Life Sciences, TTP Labtech, VWR International, LLC., Promega Corporation, Worthington Industries, BD, RUCDR Infinite Biologics, and Modul-Bio.

The rising investments on the drug discovery and drug development owing to the surging prevalence of chronic diseases such as Alzheimer’s and cancer among the global population is driving the growth of the biobanking market.

Europe was the leading biobanking market in 2024 and will lead in the near future.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us